too early for licensing deal (imo)
good to pay attention to what else is going on coz ATX doesn’t operate in a vacuum. Several FAK inhibitors in development, the one from Verastem oncology looks the most advanced. They also tout theirs as “best in class”!!
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-21
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $37.01M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.5¢ | $29.17K | 210.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 63244 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 65766 | 3 |
View Market Depth
| Last trade - 13.04pm 19/08/2024 (20 minute delay) ? |
| ATX (ASX) Chart |